Y10S 530/828
Cancer
Y10S530/828 (Cancer) appears on 525 US grants and 537 published applications in this corpus.
Search patents in Y10S- Granted patents
- 525
- Published applications
- 537
- Assignees
- 193
- Inventors
- 623
- Latest grant
- 9 Jun 2015
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 2 | 0 |
| 1977 | 0 | 0 |
| 1978 | 3 | 0 |
| 1979 | 8 | 0 |
| 1980 | 7 | 0 |
| 1981 | 4 | 0 |
| 1982 | 5 | 0 |
| 1983 | 6 | 0 |
| 1984 | 9 | 0 |
| 1985 | 15 | 0 |
| 1986 | 0 | 0 |
| 1987 | 9 | 0 |
| 1988 | 8 | 0 |
| 1989 | 25 | 0 |
| 1990 | 18 | 0 |
| 1991 | 18 | 0 |
| 1992 | 10 | 0 |
| 1993 | 11 | 0 |
| 1994 | 9 | 0 |
| 1995 | 12 | 0 |
| 1996 | 15 | 0 |
| 1997 | 19 | 0 |
| 1998 | 24 | 0 |
| 1999 | 25 | 0 |
| 2000 | 25 | 0 |
| 2001 | 12 | 3 |
| 2002 | 15 | 13 |
| 2003 | 13 | 433 |
| 2004 | 10 | 34 |
| 2005 | 4 | 17 |
| 2006 | 12 | 10 |
| 2007 | 72 | 4 |
| 2008 | 69 | 9 |
| 2009 | 13 | 5 |
| 2010 | 8 | 8 |
| 2011 | 2 | 0 |
| 2012 | 4 | 0 |
| 2013 | 3 | 0 |
| 2014 | 0 | 0 |
| 2015 | 1 | 1 |
By publication year. Applications have been published since 2001.
Recent patents
- Compositions employing alternative reading frame polypeptides for the treatment of cancer and infectious disease9 Jun 2015US 9,051,385 B2Dendreon Corporation
- Tumour-associated peptides that bind to MHC molecules17 Sep 2013US 8,536,304 B2Immatics Biotechnologies GmbH
- Peptides for development of diagnostic and therapeutic agents and methods of using same19 Mar 2013US 8,399,202 B2Prince Henry's Institute of Medical Research
- Tumour-associated peptides that bind to MHC molecules19 Mar 2013US 8,399,613 B2Immatics Biotechnologies GmbH
- Kit for detection of telomerase reverse transcriptase nucleic acids17 Jul 2012US 8,222,392 B2Geron Corporation
- Compositions employing alternative reading frame polypeptides for the treatment of cancer and infectious disease3 Dec 2015US 2015/0344543 A1
- Tumour-Associated Peptides that Bind to MHC Molecules22 Jul 2010US 2010/0183644 A1Immatics Biotechnologies GmbH
- Tumour-Associated Peptides that Bind to MHC Molecules22 Jul 2010US 2010/0184211 A1Immatics Biotechnologies GmbH
- Compositions and methods for wt1 specific immunotherapy1 Jul 2010US 2010/0166738 A1
- cDNA Encoding a Gene Bog (B5T Over-Expressed Gene) and its Protein Product27 May 2010US 2010/0129791 A1The Government of the United State, as represented by the Secretary, Dept. of Health & Human Service
Most cited
By later US patents
- Antibody conjugates for the delivery of compounds to target sites546US 4,671,958 ACytogen Corporation · 1987
- Antibody-therapeutic agent conjugates288US 4,867,973 ACytogen Corporation · 1989
- Compositions for targeting the vasculature of solid tumors254US 6,051,230 ABoard of Regents, The University of Texas System · 2000
- Anti-cancer drugs for the treatment of melanomas and method for preparing thereof173US 4,414,148 ASanofi · 1983
- Human retrovirus-related products and methods of diagnosing and treating conditions associated with said retrovirus153US 4,777,127 ALabsystems Oy · 1988